Photomedicine Devices & Technologies Market Research Report by Technology (Dichroic Lamps, Full Spectrum Light, and Laser), Application, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19
New York, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Photomedicine Devices & Technologies Market Research Report by Technology, Application, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19" - https://www.reportlinker.com/p06300985/?utm_source=GNW The Global Photomedicine Devices & Technologies Market size was estimated at USD 481.35 million in 2021 and expected to reach USD 510.56 million in 2022, and is projected to grow at a CAGR 6.32% to reach USD 695.45 million by 2027. Market Statistics: The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period. Market Segmentation & Coverage: This research report categorizes the Photomedicine Devices & Technologies to forecast the revenues and analyze the trends in each of the following sub-markets: Based on Technology, the market was studied across Dichroic Lamps, Full Spectrum Light, Laser, Light Emitting Diodes, and Polychromatic Polarized Light. Based on Application, the market was studied across Dental Procedures, Dermatology, Hair Removal, Neonatal Jaundice, Oncology, Optical Diagnostics, Pain Management, Seasonal Affective Disorder, Skin Resurfacing, Tattoo Removal, and Wound Healing. Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. Cumulative Impact of COVID-19: COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market. Cumulative Impact of 2022 Russia Ukraine Conflict: We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Photomedicine Devices & Technologies market considering the current update on the conflict and its global response. Competitive Strategic Window: The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period. FPNV Positioning Matrix: The FPNV Positioning Matrix evaluates and categorizes the vendors in the Photomedicine Devices & Technologies Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape. Market Share Analysis: The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits. Competitive Scenario: The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service. Company Usability Profiles: The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Photomedicine Devices & Technologies Market, including Abbvie Inc., Aerolase Corporation, Alma Lasers Ltd, AngioDynamics, Colorado Skin & Vein, Cutera Inc, Cynosure LLC, Deleo Medical, Fotona D.O.O, Galderma Laboratories, Indus Health Care, Iridex, Lumenis Ltd., MENTOR, Merz Aesthetics, Photomedex, qbmi Photomedicine, R2 Technologies Inc, Recrose Medica, Sentient Lasers, Spectranetics Syneron Medical, Syneron Medical, and THOR Photomedicine Ltd. The report provides insights on the following pointers: 1. Market Penetration: Provides comprehensive information on the market offered by the key players 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments The report answers questions such as: 1. What is the market size and forecast of the Global Photomedicine Devices & Technologies Market? 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Photomedicine Devices & Technologies Market during the forecast period? 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Photomedicine Devices & Technologies Market? 4. What is the competitive strategic window for opportunities in the Global Photomedicine Devices & Technologies Market? 5. What are the technology trends and regulatory frameworks in the Global Photomedicine Devices & Technologies Market? 6. What is the market share of the leading vendors in the Global Photomedicine Devices & Technologies Market? 7. What modes and strategic moves are considered suitable for entering the Global Photomedicine Devices & Technologies Market? Read the full report: https://www.reportlinker.com/p06300985/?utm_source=GNW About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________
The entrepreneur Mark Cuban just took a stand in a debate that's hotly controversial in business circles and Congress.
These are the top trending tickers on Yahoo Finance after-hours on Aug. 12.
Inflation is still near multi-decade highs. Mr. Wonderful is using these stocks to fight back.
Three state-owned Chinese corporate giants announced plans Friday to remove their shares from the New York Stock Exchange, adding to a growing financial separation between the biggest global economies in the midst of a dispute over scrutiny of company audits.
Inflation has been making headlines all year, and rightly so; it’s at 40-year high levels, driven by sharp increases in the prices of gasoline and diesel fuels. But oil and its various refined products have come down in recent weeks, and so – the July inflation numbers weren’t as bad as had been feared. The overall year-over-year price increase for the month came to 8.5%, still awful, but less than the 8.7% economists had been predicting. Markets these days are rallying in response. Whether this
Five Chinese state-owned companies said they intend to delist their American depositary shares from the New York Stock Exchange, as financial regulators in Beijing and Washington remain at loggerheads over U.S. audit requirements. In separate filings to Hong Kong’s stock exchange Friday, PetroChina , China Petroleum & Chemical , Aluminum Corp. of China , China Life Insurance Co , and Sinopec Shanghai Petrochemical Co said they have notified the NYSE that they plan to voluntarily delist their American depositary shares.
Johnson & Johnson stock is hitting its lowest level since March. Here's where it's a steal of a deal.
In this article, we talk about 11 best falling stocks to buy now. If you wish to skip our detailed analysis of the latest market situation, go directly to 5 Best Falling Stocks To Buy Now. After a brutal 2022 which saw the S&P500 shed more than 21% in the first half of the year, Q2 […]
Tesla has given investors something to look forward to this coming week: a three-for-one stock split. As of the close of trading on Aug. 24, Tesla shareholders will get a “dividend” of two extra shares. The next day, Tesla stock will start trading at the new price—a third of what it used to be.
Profit warnings from Nvidia and Micron have sent a chill through chip stocks, but the long-term opportunity is still intact.
(Bloomberg) -- Principal Global Investors’ Seema Shah is no stock market bull but says the rally that erupted Wednesday may continue until the head of the Federal Reserve steps up and stops it.Most Read from BloombergStriking Drop in Stress Hormone Predicts Long Covid in StudyThe Fed’s Damage to the Housing Market May Last YearsGarland Seeks to Unseal Trump Warrant, Says He Approved SearchChina Has Painted Itself Into a Semiconductor CornerRuto, Odinga Shy of Victory in Latest Vote Counts: Kenya
For the first half of 2022, the S&P 500 fell 20.6%, its worst showing since 1970. The U.S. inflation rate for June was 9.1%. Economists are looking for it to go even higher in the months ahead. At the end of July, the Federal Reserve hiked its Fed Funds rate 75 basis points, the second consecutive time it’s done so. The benchmark Fed Funds rate is what the Federal Reserve charges banks for overnight borrowing. On top of that, a blowout nonfarm payroll jobs report for June showed an increase of 5
In this article, we discuss 10 Chinese stocks investors are shorting. If you want to skip our discussion about the turmoil in the Chinese economy, go directly to Investors are Shorting These 5 Chinese Stocks. NIO Inc. (NYSE:NIO), KE Holdings Inc. (NYSE:BEKE), and TAL Education Group (NYSE:TAL) are some of the stocks that investors are […]
The board of Devon Energy Corporation ( NYSE:DVN ) has announced that it will be paying its dividend of $1.55 on the...
Julie Biel, Kayne Anderson Rudnick Portfolio Manager and Senior Research Analyst, and Kevin Nicholson, RiverFront Investment Group Global Fixed Income CIO, sit down with Yahoo Finance Live to talk about inflation's impact on consumers, market rally trends, the outlook of the travel industry, and defensive sectors.
(Bloomberg) -- Five of China’s largest state-owned companies announced plans to delist from US exchanges as the two countries struggle to come to an agreement allowing American regulators to inspect audits of Chinese businesses.Most Read from BloombergAuthor Salman Rushdie Stabbed on Lecture Stage in New YorkTrump Calls for Release of Warrant Documents Used in SearchThe Fed’s Damage to the Housing Market May Last YearsExtreme Heat Uncovers Lost Villages, Ancient Ruins and ShipwrecksChina State-O
Berkshire Hathaway's 13F filings don't tell the full story about the company's holdings.
Guggenheim Partners analyst John DiFucci launched coverage of the group late Thursday, with some thoughts on where to place bets in the sector. DiFucci is new to Guggenheim, but a familiar name on the Street—at various times, he’s covered the software sector for Jefferies, J.P Morgan, Oppenheimer, and a couple of place that have since disappeared—Bear Stearns and Donaldson, Lufkin & Jenrette. DiFucci has Buy ratings on Oracle (ORCL), Palo Alto Networks (PANW), CrowdStrike (CRWD), Splunk (SPLK), Zscaler (ZS), and Progress Software (PRGS).
Yahoo Finance reporter Pras Subramanian discusses Rivian shares being volatile after its disappointing second-quarter earnings results.
Yahoo Finance Live looks at several Chinese stocks reportedly scheduled to de-list from the NYSE.